AVNS logo

Avanos Medical, Inc. Stock Price

NYSE:AVNS Community·US$1.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

AVNS Share Price Performance

US$24.73
12.02 (94.57%)
US$24.73
12.02 (94.57%)
Price US$24.73

AVNS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks
0 Rewards

Avanos Medical, Inc. Key Details

US$715.9m

Revenue

US$357.6m

Cost of Revenue

US$358.3m

Gross Profit

US$432.7m

Other Expenses

-US$74.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-1.59
50.05%
-10.39%
12.6%
View Full Analysis

About AVNS

Founded
2014
Employees
2287
CEO
David Pacitti
WebsiteView website
avanos.com

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Recent AVNS News & Updates

Seeking Alpha Apr 15

Avanos Medical Stock Looks Capped After American Industrial Partners' Offer

Summary Avanos Medical is now primarily an M&A play, which is unfortunate because I think it's otherwise a promising standalone business. The American Industrial Partners offer values Avanos Medical at $25 per share in cash, limiting meaningful upside for new investors. Specialty Nutrition remains the core franchise. MIC-KEY, guided placement, and NICU expansion have interesting potential. Avanos Medical looks modestly undervalued, but that matters less because the announced deal effectively caps returns. I think the main risk is deal failure, which could trigger a sharp pullback if merger-arbitrage holders exit quickly. Read the full article on Seeking Alpha

Recent updates

No updates